AHR and neoplasm: Building upon the contribution of microbial metabolites to the improvement of immunotherapeutic outcomes, another study demonstrated that Limosilactobacillus reuteri (LR) produces indole-3-aldehyde (I3A), a tryptophan-derived metabolite that activates the AHR, thereby promoting IFN-γ and enhancing anti-tumor immune responses.